Daniels I, Lindsay M A, Keany C I, Burden R P, Fletcher J, Haynes A P
Medical Research Centre, City Hospital, Nottingham, United Kingdom.
Clin Diagn Lab Immunol. 1998 Sep;5(5):683-9. doi: 10.1128/CDLI.5.5.683-689.1998.
Peritoneal dialysis effluent (PDE) contains a low-molecular-weight solute that will activate and prime the NADPH oxidase of human neutrophils via a phospholipase A2 (PLA2)-dependent mechanism. Since the products of PLA2 are known to activate and prime the oxidase we have investigated their role in the dialysis effluent-mediated activation and priming of human neutrophils. NADPH oxidase activity of PDE-primed and -unprimed neutrophils was measured by lucigenin-enhanced chemiluminescence in the presence of known inhibitors of the arachidonic acid cascade. Incubation of neutrophils with the nonselective PLA2 inhibitor quinacrine (0 to 100 microM) reduced oxidase activity in both primed and unprimed cells. Furthermore, primed cells were more sensitive to the action of quinacrine than were unprimed cells. We were unable to determine the relative roles of secretory PLA2 (sPLA2) and cytosolic PLA2 (cPLA2) since the selective sPLA2 inhibitor scalaradial (0 to 100 microM) inhibited oxidase activity in both groups of cells by similar degrees, while the specific cPLA2 inhibitor AACO-CF3 (0 to 50 microM) failed to affect activity in either group. Inhibition of platelet-activating factor (PAF), cycloxygenase, and 5-lipoxygenase-activating protein by hexanolamino-PAF (0 to 25 microM), flurbiprofen (0 to 25 microM), and MK886 (0 to 5 microM), respectively, had no effect upon oxidase activity. However, the direct inhibition of 5-lipoxygenase by caffeic acid or lipoxin A4 resulted in a similar concentration-dependent attenuation of oxidase activity in both primed and unprimed cells. Leukotriene B4 (LTB4) release from primed neutrophils was comparable to that from unprimed cells with the exception of phorbol myristate acetate-stimulated cells, which released fivefold more LTB4 than control. Taken together, these results suggest that it is arachidonic acid per se, and not its metabolites, that is important in priming of the neutrophil NADPH oxidase by dialysis effluent.
腹膜透析流出液(PDE)含有一种低分子量溶质,该溶质可通过磷脂酶A2(PLA2)依赖性机制激活并启动人类中性粒细胞的NADPH氧化酶。由于已知PLA2的产物可激活并启动氧化酶,我们研究了它们在透析流出液介导的人类中性粒细胞激活和启动中的作用。在存在花生四烯酸级联反应的已知抑制剂的情况下,通过光泽精增强的化学发光法测量PDE启动和未启动的中性粒细胞的NADPH氧化酶活性。用非选择性PLA2抑制剂喹吖因(0至100 microM)孵育中性粒细胞可降低启动和未启动细胞中的氧化酶活性。此外,启动细胞比未启动细胞对喹吖因的作用更敏感。由于选择性sPLA2抑制剂司拉氯铵(0至100 microM)以相似程度抑制两组细胞中的氧化酶活性,而特异性cPLA2抑制剂AACO-CF3(0至50 microM)未能影响任一组的活性,因此我们无法确定分泌型PLA2(sPLA2)和胞质型PLA2(cPLA2)的相对作用。己醇氨基-PAF(0至25 microM)、氟比洛芬(0至25 microM)和MK886(0至5 microM)分别抑制血小板活化因子(PAF)、环氧化酶和5-脂氧合酶激活蛋白,对氧化酶活性没有影响。然而,咖啡酸或脂oxin A4直接抑制5-脂氧合酶导致启动和未启动细胞中的氧化酶活性出现类似的浓度依赖性衰减。除佛波醇肉豆蔻酸酯乙酸酯刺激的细胞外,启动的中性粒细胞释放的白三烯B4(LTB4)与未启动细胞释放的相当,前者释放的LTB4比对照多五倍。综上所述,这些结果表明,在透析流出液启动中性粒细胞NADPH氧化酶的过程中,重要的是花生四烯酸本身,而非其代谢产物。